Presentation TCT 2023 TCT 368: Optimal Timing of Invasive Strategy in Patients with High-Risk Non-ST-Elevation Acute Coronary Syndrome: A Meta-Analysis Presenter: Jae-Sik Jang October 26, 2023
News Conference News TCT 2021 FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results Todd Neale November 03, 2021
News Conference News TCT 2020 Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19 Michael O'Riordan October 14, 2020
News Conference News TCT 2019 TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients Todd Neale October 03, 2019
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Conference News TCT 2017 FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost L.A. McKeown November 02, 2017
News Conference News TCT 2017 No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy Michael O'Riordan October 30, 2017
News Conference News TCT 2015 Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award October 12, 2015
News Conference News TCT 2014 SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD September 14, 2014
News Conference News Hybrid Coronary Revascularization Associated with Fast Recovery November 07, 2011